These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15678518)

  • 1. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.
    Al MJ; Feenstra TL; Hout BA
    Health Econ; 2005 Jul; 14(7):655-67. PubMed ID: 15678518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portfolio evaluation of health programs: a reply to Sendi et al.
    Bridges JF; Terris DD
    Soc Sci Med; 2004 May; 58(10):1849-51. PubMed ID: 15020002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramsey waits: allocating public health service resources when there is rationing by waiting.
    Gravelle H; Siciliani L
    J Health Econ; 2008 Sep; 27(5):1143-54. PubMed ID: 18468707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2004 May; 58(10):1853-5. PubMed ID: 15020003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allocating health care resources when people are risk averse with respect to life time.
    Hoel M
    Health Econ; 2003 Jul; 12(7):601-8. PubMed ID: 12825211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation in cardiology.
    Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
    Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
    Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portfolio theory and cost-effectiveness analysis: a further discussion.
    Sendi P; Al MJ; Rutten FF
    Value Health; 2004; 7(5):595-601. PubMed ID: 15367254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.
    Sendi P; Al MJ
    Soc Sci Med; 2003 Sep; 57(6):969-74. PubMed ID: 12878098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
    Elbasha EH
    Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-utility analysis; uncertainties restrict applicability].
    de Neeling JN
    Ned Tijdschr Geneeskd; 2004 May; 148(22):1106-10. PubMed ID: 15198066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of budget impact in drug reimbursement decisions.
    Cohen JP; Stolk E; Niezen M
    J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving research into practice: A decision framework for integrating home telehealth into chronic illness care.
    Hebert MA; Korabek B; Scott RE
    Int J Med Inform; 2006 Dec; 75(12):786-94. PubMed ID: 16872892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic approach to clinical trial design and research priority-setting.
    Claxton K; Posnett J
    Health Econ; 1996; 5(6):513-24. PubMed ID: 9003938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priority setting in health care: disentangling risk aversion from inequality aversion.
    Echazu L; Nocetti D
    Health Econ; 2013 Jun; 22(6):730-40. PubMed ID: 22736580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.